Submit a Manuscript
F6Publishing
Publisher Login
Manuscript Statistics
Articles In Press
1
Zhang T, Liu JL, Wang W, Ren K, Liu XM, Cao K, Li Z, Cheng XY, Zhang XY, Xu WS. Lipid metabolism disorders and osteoarthritis progression: Potential intervention with plant active ingredients. World J Orthop 2025; In press
2025-12-04 | Browse: 0 | Download: 0
2
Xie YT, Liu Q, Liu YX. Domino effect of evening chronotype: How chronotype topples adolescent mental health through sleep and social functioning. World J Psychiatry 2025; In press
2025-12-04 | Browse: 2 | Download: 0
3
Amalou K, Benboudiaf N, Medkour MT, Belghanem F, Chetroub H, Rekab R, Belloula A, Bouaouina F, Saidani K. Lactated Ringer’s solution in combination with indomethacin for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A prospective, randomized trial. World J Gastrointest Endosc 2025; In press
2025-12-04 | Browse: 0 | Download: 0
4
Gao YP, Lu YY. Time series analysis of anxiety and depression during pregnancy to postpartum depression based on cross-lagged model. World J Psychiatry 2025; In press
2025-12-04 | Browse: 0 | Download: 0
5
Tian Y, Liu GQ, Li CF, Tian QM, Qiao S. Colossal well-differentiated liposarcoma of the small bowel mesentery: A case report. World J Gastrointest Oncol 2025; In press
2025-12-04 | Browse: 9 | Download: 0
6
Joseph A, Mathew S, Nair HR. Blood markers versus transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2025; In press
2025-12-04 | Browse: 0 | Download: 0
7
Bu F, Zhang SY, Liu ZJ. Anesthesiologist’s perspective on endoscopic submucosal dissection: Bridging minimally invasive surgery and enhanced recovery after surgery management. World J Gastrointest Surg 2025; In press
2025-12-04 | Browse: 1 | Download: 0
8
de la Plaza Llamas R, Ribera Díaz D, Betancor Díaz P, Díaz Candelas DA, Latorre-Fragua RA, Gorini L, Arellano González R, Gemio del Rey IA. Staging laparoscopy in esophagogastric junction cancer: Systematic review and meta-analysis. World J Gastrointest Surg 2025; In press
2025-12-04 | Browse: 2 | Download: 0
9
Boscarelli A. Role of plasma D-dimer levels as diagnostic and prognostic marker in neonatal sepsis: An insightful support. World J Clin Pediatr 2025; In press
2025-12-04 | Browse: 0 | Download: 0
10
Ramos-Gregorio CO, Tremillo-Maldonado O, Silveira F, Schuch LF, Pereira-Prado V, Sicco E, Soto-Najera AC, GomezPalacio-Gastélum M, Isiordia-Espinoza M, Muñoz-Ibarra JJ, Toral-Rizo V, Bologna-Molina R. Multifocal epithelial hyperplasia: Clinical features, diagnosis and management challenges. World J Exp Med 2025; In press
2025-12-04 | Browse: 1 | Download: 0
11
Liang LP, Zhang L, Jin DD, Zhang SH, Liu L. Beyond anti-inflammatory strategies: Epigenetic targets as emerging therapeutic frontiers in acute pancreatitis. World J Gastroenterol 2025; In press
2025-12-04 | Browse: 0 | Download: 0
12
Alam R. Atypical presentation of pediatric acute hepatitis A: Is the situation alarming? World J Virol 2025; In press
2025-12-03 | Browse: 14 | Download: 0
13
Bilotta AJ, Trebilcock JA, Hebda NJ, Sasan CK, Cooper KM, Rupawala AH. Artificial intelligence in the management of inflammatory bowel disease: What’s next? World J Gastrointest Pharmacol Ther 2025; In press
2025-12-03 | Browse: 20 | Download: 0
14
Ma CX, Chen J, Wang JL, Pei S, Zhang ZJ, Xie YS, He X. Co-expression of cancer stem cell markers CD24 and CD133 in gastric cancer tissues: Clinicopathological and prognostic significance. World J Stem Cells 2025; In press
2025-12-03 | Browse: 17 | Download: 0
15
Fu MY, Jia K, Lee C, O’Neill RS, Thilakanathan C, Turner I. Double-hit primary high-grade gastric B-cell lymphoma presenting with pancytopaenia and atraumatic back pain: A case report. World J Gastrointest Pharmacol Ther 2025; In press
2025-12-03 | Browse: 15 | Download: 0
16
Huang AX, Gao DK, Xie HY, Luo G, Hong L, Zhou YL, Wang Y. Clinical application and expansion of paclitaxel-coated balloons in coronary atherosclerotic disease. World J Cardiol 2025; In press
2025-12-03 | Browse: 14 | Download: 0
17
Abdelkreem E, Labeeb YS, Mohamed MA. Efficacy of vitamin D supplementation for children with acute bronchiolitis: A randomized controlled trial. World J Clin Pediatr 2025; In press
2025-12-03 | Browse: 14 | Download: 0
18
Chen YX, Zhang YH, Mo SJ. Role of microRNA-136 in Helicobacter pylori-induced early-stage gastric cancer: Mechanistic insights and future directions. World J Gastrointest Oncol 2025; In press
2025-12-03 | Browse: 15 | Download: 0
19
Keshav K, Kaustubh K, Mishra P. Effect of teriparatide on improving fracture union in osteoporotic intertrochanteric fractures: A systematic review and meta-analysis. World J Orthop 2025; In press
2025-12-03 | Browse: 19 | Download: 0
20
Zhao JD, Qiu SW, Lin KY, Lin HY, Yu CW. Risk factors and early identification markers for post-ischemic stroke anxiety and depression. World J Psychiatry 2025; In press
2025-12-03 | Browse: 11 | Download: 0
813 items  Read more >>
Author Reviews
1
"I greatly appreciate the assistance provided by the editorial office. Their work efficiency is amazing, and their professionalism ..."  [Read more]
"I greatly appreciate the assistance provided by the editorial office. Their work efficiency is amazing, and their professionalism is commendable. The reviewers they recommended completed the review work very professionally, which can promote us to better improve the manuscript. I hope more high-quality papers can be published in your journal. "  [Collapse]
Xu JH, Liu Y. Organ preservation in esophageal cancer treatment, is it time now? World J Gastroenterol 2025; 31(45): 112287
2
"On behalf of all co-authors, I would like to extend our deep appreciation to the Editor and Reviewers for their careful evaluation ..."  [Read more]
"On behalf of all co-authors, I would like to extend our deep appreciation to the Editor and Reviewers for their careful evaluation of our manuscript and for providing thoughtful and constructive feedback. The reviewers’ comments were highly valuable in guiding us to improve the manuscript’s clarity, coherence, and scientific rigor. We have thoroughly addressed every point raised during the review process. In revising the manuscript, we incorporated additional explanations where needed, refined the presentation of our results, and enhanced the overall precision of the text. These efforts have, in our view, substantially strengthened the manuscript and increased its relevance for the readership of the World Journal of Gastroenterology. We are grateful for the opportunity to revise and resubmit our work, and we sincerely hope that the improved version meets your expectations. We look forward to your further comments and to contributing to the ongoing scientific dialogue in this field. "  [Collapse]
Yang D, Kim B, Kim JW. Mechanistic insights into hepatic cell type-specific contributions to acetaminophen-induced acute liver injury. World J Gastroenterol 2025; 31(45): 112720
3
"On behalf of all authors, I would like to express our sincere gratitude to the Editor and the Reviewers for their valuable time and ..."  [Read more]
"On behalf of all authors, I would like to express our sincere gratitude to the Editor and the Reviewers for their valuable time and constructive comments. Their insightful suggestions have significantly helped us in improving the clarity, logic, and scientific rigor of this manuscript. We have carefully addressed all points raised during the peer-review process. The revised version has been strengthened through additional explanations, refined data presentation, and more precise language. We believe these revisions have enhanced the overall quality and impact of our work, making it more valuable for the readership of the World Journal of Gastroenterology. We appreciate this opportunity to contribute to the field. Look forward to your feedback and citations. "  [Collapse]
Wang J, Chang L, Niu DF, Yan Y, Cao CQ, Li SJ, Wu Q. Diagnostic accuracy of stereomicroscopy assessment of invasion depth in ex vivo specimens of early gastric cancer. World J Gastroenterol 2025; 31(45): 112518
4
"Through the joint efforts of the assistant editor, editor, peer reviewers, editorial director, editor-in-chief, language editor, and ..."  [Read more]
"Through the joint efforts of the assistant editor, editor, peer reviewers, editorial director, editor-in-chief, language editor, and production editor, the entire publication process for this manuscript has been completed. This article was further revised and improved, and was successfully published in World Journal of Gastroenterology. I would like to express my gratitude to all of you for your efforts. "  [Collapse]
Zhang N, Wang Y, Fang SS, Han M, Zheng QW, Zhu YY, Zhang MY, Li JJ, Cui LX, Tian JL, Deng YH, Zhu SL, Ni HM, Zhou L, Zuo GL, Huang TS, Liao Q, Li XQ, Shang YY, Wang YJ, Tian Y, Ge LY, Han HQ, Hu WM, Jiang Y, Li YJ, Mao X, Yang LH, Yao JM, Zheng X, Wang HW, Fang SQ. Clinical characteristics and risk factors of refractory gastroesophageal reflux disease: A multicenter cross-sectional study. World J Gastroenterol 2025; 31(45): 113060
5
"I hold a high opinion of your journal’s services across all essential aspects: the well-prepared forms for online full-text submission, ..."  [Read more]
"I hold a high opinion of your journal’s services across all essential aspects: the well-prepared forms for online full-text submission, the smooth article publication process, the clear provision of academic rules and standards, and the thorough academic misconduct detection report. The reasonable publication period, detailed editing and publishing norms, appropriate duration dedicated to peer review, and rigorous anonymous peer review process all meet my expectations. The peer review report has been particularly valuable for refining my manuscript, and I am confident in its fairness and objectivity as it focuses solely on academic merit. "  [Collapse]
Lei ZL, Tan ZL, Luo YH, Yang M, Wang JL, Qin Z, Liu YY. Comparison of the efficacy of laparoscopic hepatectomy and radiofrequency ablation for small hepatocellular carcinoma: A retrospective study. World J Gastroenterol 2025; 31(45): 111540
6
"Overall, I am satisfied with the journal’s editorial and peer-review process. The submission system was easy to use, and the ..."  [Read more]
"Overall, I am satisfied with the journal’s editorial and peer-review process. The submission system was easy to use, and the communication with the editorial office was clear and timely. The peer review reports were constructive and provided valuable guidance that helped improve the quality of the manuscript. The editorial team demonstrated professionalism throughout the process, and the final publication, including formatting, figures, and tables, met a high standard. However, there is still room for improvement. In particular, the duration of the review and publication process could be further optimized to enhance efficiency. Additionally, ensuring greater consistency in the depth and specificity of reviewers’ comments would further strengthen the peer review experience for authors. In summary, my overall experience with the journal has been positive, and I appreciate the efforts made by both reviewers and editors in maintaining academic rigor and publication quality. "  [Collapse]
Zhang WY, Yang K, Zhai YC, Miao QS, Cui YH. Mental vulnerability, family dysfunction, and digital exposure: Overlooked burdens in populations with noncommunicable chronic diseases. World J Psychiatry 2025; 15(12): 112122
7
"We are highly satisfied with the submission and review system of this journal, which is also a journal of high academic value. We ..."  [Read more]
"We are highly satisfied with the submission and review system of this journal, which is also a journal of high academic value. We will continue to submit our work. The efficiency and thoroughness of the review process have greatly contributed to our positive experience, reinforcing our commitment to sharing our research through this esteemed platform. "  [Collapse]
Pan JL, Xing H, Li Y, Chang ZQ. Successful treatment of a non-healing lumbar incision post-radiotherapy using vacuum sealing drainage: A case report. World J Orthop 2025; 16(11): 112307
8
"Dear sir everthing is perfect, all the reviewer comments were structured highly scientific and helpful to improve manuscript quality ..."  [Read more]
"Dear sir everthing is perfect, all the reviewer comments were structured highly scientific and helpful to improve manuscript quality and made the message from it more clear handeling by the editor was so proficinal regarding continuous follow up, rigorous revision i am so honored that my work published in your journal thank you so much "  [Collapse]
Hegazy MAE. Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: Machine learning for non-invasive diagnosis and risk stratification. World J Hepatol 2025; 17(11): 111354
9
"I am very pleased with my experience publishing in the World Journal of Clinical Cases through the F6Publishing platform. The ..."  [Read more]
"I am very pleased with my experience publishing in the World Journal of Clinical Cases through the F6Publishing platform. The submission process was smooth, transparent, and well-organized, and the editorial team provided timely communication at every stage. The peer-review comments were constructive and helped enhance the quality of my work. Overall, I am fully satisfied and highly recommend this journal and publishing system to other researchers. "  [Collapse]
Gecer IS, Tabaru A, Yilmaz B, Kaya E, Kaya Tutar N, Gumuslu B, Oktay MF. Medial olivocochlear reflex dysfunction in multiple sclerosis: The influence of brainstem lesion localization and its clinical implications. World J Clin Cases 2025; 13(28): 108180
10
"As an author, I was very satisfied with both the editorial and publishing process and the quality of peer review provided by the ..."  [Read more]
"As an author, I was very satisfied with both the editorial and publishing process and the quality of peer review provided by the journal. Communication was clear and timely, the instructions were transparent, and the editorial handling was efficient and professional. The reviewers’ comments were constructive, specific, and scientifically sound, helping to improve the clarity and impact of the manuscript. Overall, I consider the journal reliable and its peer review process rigorous, fair, and respectful. "  [Collapse]
Tarallo M, Crocetti D, Coppola A, Iannone I, Lamazza A, Sapienza P, Fiori E. Endoscopic retrograde cholangiopancreatography-related adverse events: What is the role of surgery today? World J Gastrointest Surg 2025; 17(7): 107385
11
"Our experience with the World Journal of Gastrointestinal Surgery has been exceptionally positive. The peer-review process for our ..."  [Read more]
"Our experience with the World Journal of Gastrointestinal Surgery has been exceptionally positive. The peer-review process for our manuscript on asymptomatic gallstone disease was smooth, transparent, and conducted with admirable professionalism. We greatly appreciated the timely communication, constructive feedback, and consistent editorial support throughout the process. The efficiency and clarity demonstrated by the Baishideng Publishing Group made the publication journey both enriching and seamless. We extend our sincere thanks to the editors, reviewers, and the entire team for their commitment to high scientific standards. "  [Collapse]
Sasmal PK, Singh PK, Sahoo A, Dutta T. Asymptomatic gallstone disease: Re-evaluating the threshold for surgical options in the era of precision medicine. World J Gastrointest Surg 2025; 17(11): 110501
12
"I would like to extend my sincere gratitude to the journal's editorial staff and the external reviewers. The editorial handling was ..."  [Read more]
"I would like to extend my sincere gratitude to the journal's editorial staff and the external reviewers. The editorial handling was highly professional and efficient. The reviewers provided rigorous, insightful, and truly constructive feedback, which substantially improved the scholarly quality of the manuscript. The entire publication experience was excellent. Thank you. "  [Collapse]
Liu Y, Shan XQ, Li YJ, Gao WL, Zhao L. Role of human umbilical cord mesenchymal stem cells in diabetic kidney disease. World J Stem Cells 2025; 17(11): 113201
13
"It is a great honor for my article to be published in your esteemed journal. I am extremely grateful for the guidance provided by ..."  [Read more]
"It is a great honor for my article to be published in your esteemed journal. I am extremely grateful for the guidance provided by the editors and peer reviewers. The entire publication process was very smooth, and the editors were very patient and professional. I wish your journal continued success. "  [Collapse]
Sun ZY, Ye L, Mao YY, Liang L. Effect of enhanced recovery after surgery nursing on gastrointestinal recovery function and life quality in patients laparoscopic cholecystectomy. World J Gastrointest Surg 2025; 17(11): 108188
14
"Dear Editorial Team Hepatocellular carcinoma is one of the most common cancers worldwide and is often diagnosed at an advanced stage, ..."  [Read more]
"Dear Editorial Team Hepatocellular carcinoma is one of the most common cancers worldwide and is often diagnosed at an advanced stage, making accurate recognition and prediction of its biological behavior critically important for clinicians. Having our review on ensemble learning approaches for HCC published in such a distinguished journal is truly gratifying. I hope clinicians and researchers find these insights useful in improving diagnostic accuracy, refining prognostic modeling, and ultimately enhancing patient outcomes through more robust, data-driven decision-making Best regards "  [Collapse]
Akbulut S, Colak C. Explainable artificial intelligence and ensemble learning for hepatocellular carcinoma classification: State of the art, performance, and clinical implications. World J Hepatol 2025; 17(11): 109494
15
"Dear Editorial team Having my work published in such a prestigious and internationally respected journal is truly meaningful for me. ..."  [Read more]
"Dear Editorial team Having my work published in such a prestigious and internationally respected journal is truly meaningful for me. I am sincerely pleased to see our efforts recognized at this level, and I genuinely hope that readers will benefit from the insights and contributions presented in this valuable article. Best regards "  [Collapse]
Akbulut S, Kucukakcali Z, Colak C. Artificial intelligence in acute appendicitis: A comprehensive review of machine learning and deep learning applications. World J Gastroenterol 2025; 31(43): 112000
16
"We are happy with the submission. I hope that y the editor can provide us with additional invited papers. We look forward to working ..."  [Read more]
"We are happy with the submission. I hope that y the editor can provide us with additional invited papers. We look forward to working with BPG. The reviewing process needs work. It takes numerous months before reviewers are found. The system could be improved by slimlining the entire submission process. Other journals take 1-2 for complete publication. "  [Collapse]
Zeppieri M, Musa M, Cordeiro MF, Gagliano C, D’Esposito F. Reevaluating Usher syndrome: Transitioning from traditional subtypes to precision diagnosis. World J Med Genet 2025; 13(1): 112991
17
"The journal provided an exceptionally thorough and constructive review process. The feedback was clear, insightful, and helped ..."  [Read more]
"The journal provided an exceptionally thorough and constructive review process. The feedback was clear, insightful, and helped strengthen the overall quality of the manuscript. The editorial team ensured that the tables were presented with excellent clarity and organization, enhancing the readability of the results. I also appreciated the efficient and transparent publication workflow. Overall, this journal demonstrates professionalism, high academic standards, and a strong commitment to authors. "  [Collapse]
Nagesh VK, Martinez E, Badam S, Harrison JL, Basta M, Varughese VJ, Anwar GR, Deshpande V, Francis D, Islek D, Pulipaka SP, Bhuju R, Moliya P, Niazi B, Elias S. Management of acute liver failure-an updated literature review. World J Crit Care Med 2025; 14(4): 108840
18
"We are very pleased that the manuscript we submitted to World Journal of Clinical Oncology has been accepted and puslided in this ..."  [Read more]
"We are very pleased that the manuscript we submitted to World Journal of Clinical Oncology has been accepted and puslided in this prestigious journal. We are grateful to the reviewing process and we have no further comments to submit thank you in advance kind regards. We will submit in the future for our work. "  [Collapse]
Seretis F, Panagaki A, Gkolfakis P, Tziatzios G, Paraskeva K. Endoscopic assessment of rectal cancer response after neoadjuvant chemoradiotherapy: A narrative literature review. World J Clin Oncol 2025; 16(11): 106498
19
"The review process itself was fine, but the submission site/online portal had some issues. There was also clearly come confusion on ..."  [Read more]
"The review process itself was fine, but the submission site/online portal had some issues. There was also clearly come confusion on the editor side of things as we kept receiving different decisions and different proofs almost like multiple separate people were handling our submission and not communicating with one another, which directly contributed to how long the entire process took. "  [Collapse]
Merhavy ZI, Raeburn T, Torres-Ayala GM, McCulloch MA, Varkey TC. Sedation and analgesia strategies in the neuro intensive care unit. World J Crit Care Med 2025; 14(4): 111787
20
"We are extremely grateful to the editorial department for allowing our article to be published in such an excellent journal as WJGO. ..."  [Read more]
"We are extremely grateful to the editorial department for allowing our article to be published in such an excellent journal as WJGO. We are also grateful to the reviewers for their suggestions in improving the quality of the article. Finally, we are thankful to the editorial department for helping to ensure the smooth publication of our article. "  [Collapse]
Yang XM, Sun W, He YG, Peng XH, You N, Tang YC, Zheng L, Huang XB. Patient-derived organoids for the personalized treatment of pancreatic neuroendocrine tumor with liver metastases: A case report. World J Gastrointest Oncol 2025; 17(11): 112385
20123 items  Read more >>
Article Quality Tracking-Peer-Review
1
"This study analyzes RSPO3 rearrangements in advanced colorectal cancer (aCRC) and their clinical implications. Among 73 patients with ..."  [Read more]
"This study analyzes RSPO3 rearrangements in advanced colorectal cancer (aCRC) and their clinical implications. Among 73 patients with stage pT4a‑b tumors, RSPO3 fusions were detected in 8% of cases, predominantly in right‑sided or transverse colon cancers. These rearrangements were associated with smaller tumor size, normal carcinoembryonic antigen levels, microsatellite stability, and significantly poorer overall survival. The authors also confirmed through in silico analyses that elevated RSPO3 expression correlates with worse recurrence‑free and overall survival in independent CRC cohorts. Strengths of the work include comprehensive next‑generation sequencing of 50 cancer‑related genes, detailed clonal evolution analysis, and integration of clinical, pathological, and molecular data. Overall, the study highlights RSPO3 fusions as a potential prognostic biomarker and therapeutic target in advanced colorectal cancer."  [Collapse]
Tur R, Abad M, Filipovich E, Rivas MB, Rodriguez M, Montero JC, Sayagués JM. RSPO3 rearrangements in advanced colorectal cancer patients and their relationship with disease characteristics. World J Gastrointest Oncol 2025; 17(11): 112838
2
"This retrospective study develops and validates a novel nomogram model to predict survival outcomes in advanced HER‑2 negative gastric ..."  [Read more]
"This retrospective study develops and validates a novel nomogram model to predict survival outcomes in advanced HER‑2 negative gastric cancer patients treated with immunochemotherapy. Using data from 200 patients who received sintilimab plus chemotherapy, the authors identified PD‑L1 expression, microsatellite status, TNM stage, tumor differentiation, neutrophil‑to‑lymphocyte ratio, and the C‑reactive protein–albumin–lymphocyte (CALLY) index as independent prognostic factors. The resulting models demonstrated strong discrimination (C‑index 0.78–0.82) and calibration, with high accuracy for progression‑free and overall survival across multiple time points. Strengths of the work include integration of molecular, clinical, and inflammatory markers into a single predictive tool, rigorous statistical validation, and clear demonstration of clinical applicability. Overall, the study provides a robust framework for individualized risk assessment and treatment planning in HER‑2 negative advanced gastric cancer."  [Collapse]
Yao ZY, Bao G, Li GC, Hao QL, Ma LJ, Rao YX, Xu K, Ma X, Han ZX. Survival prognosis in advanced HER-2 negative gastric cancer treated with immunochemotherapy: A novel model. World J Gastrointest Oncol 2025; 17(11): 112981
3
"This meta‑analysis evaluates the efficacy of neoadjuvant immunotherapy combined with radiotherapy and chemotherapy in locally advanced ..."  [Read more]
"This meta‑analysis evaluates the efficacy of neoadjuvant immunotherapy combined with radiotherapy and chemotherapy in locally advanced rectal cancer (LARC). Across 15 studies involving 796 patients, the addition of immunotherapy significantly improved major pathological response, pathological complete response, and clinical complete response, particularly in patients with proficient mismatch repair (pMMR) and microsatellite stability. Rates of R0 resection and sphincter‑preserving surgery were also higher, while adverse events such as hematologic toxicity and liver dysfunction remained within acceptable limits. Strengths of the study include comprehensive literature retrieval, rigorous subgroup and sensitivity analyses, and clear reporting of heterogeneity and publication bias. Overall, the findings suggest that integrating immunotherapy into neoadjuvant chemoradiotherapy regimens enhances remission and organ preservation without substantially increasing complications, supporting its consideration as a first‑line strategy for LARC."  [Collapse]
Yan WX, Yuan HQ, Xiong ZY, Qin LJ, Wu J, He J, Mu J, Li J, Li N. Meta-analysis of the efficacy of neoadjuvant immunotherapy combined with radiotherapy and chemotherapy for locally advanced rectal cancer. World J Gastrointest Oncol 2025; 17(11): 113048
4
"This study investigates folate receptor–positive circulating tumor cells (FR+ CTCs) as potential biomarkers for hepatocellular ..."  [Read more]
"This study investigates folate receptor–positive circulating tumor cells (FR+ CTCs) as potential biomarkers for hepatocellular carcinoma (HCC). In a retrospective cohort of 128 patients, FR+ CTC counts demonstrated superior diagnostic accuracy compared to alpha‑fetoprotein (AFP), with sensitivity of 90% and specificity of 77%. Elevated FR+ CTC levels correlated with adverse pathological features such as larger tumor size, multiple lesions, macrovascular invasion, and extrahepatic metastasis. Importantly, higher baseline FR+ CTC counts predicted shorter disease‑free survival after hepatectomy, with a cutoff of 12.9 FU/3 mL distinguishing high‑risk patients. Strengths of the work include rigorous methodology using ligand‑target PCR, clear statistical validation with ROC and Cox regression analyses, and demonstration that FR+ CTCs may serve both diagnostic and prognostic roles independent of AFP. These findings provide promising evidence that FR+ CTC quantification could enhance patient stratification, guide treatment evaluation, and improve recurrence prediction in HCC."  [Collapse]
Zhang ZY, Zhou M, Liu JJ, Zhang W. Folate receptor-positive circulating tumor cells might function as potential biomarkers for hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(11): 113431
5
"This article presents two rare case reports of gastrointestinal stromal tumors (GISTs) driven by novel FGFR2 fusions, expanding the ..."  [Read more]
"This article presents two rare case reports of gastrointestinal stromal tumors (GISTs) driven by novel FGFR2 fusions, expanding the molecular spectrum beyond the well‑known KIT and PDGFRA mutations. Both patients underwent successful surgical resection followed by adjuvant imatinib therapy, achieving sustained remission over more than two years. The study is well executed in several respects: it highlights the importance of comprehensive genomic profiling with next‑generation sequencing to uncover actionable mutations, demonstrates that even non‑canonical alterations may respond to standard tyrosine kinase inhibitors, and underscores the potential of FGFR‑targeted therapies for imatinib‑resistant or advanced disease. By carefully documenting clinical, pathological, and molecular features, the authors provide valuable preliminary evidence that FGFR2 fusions may define a distinct, therapeutically relevant GIST subtype."  [Collapse]
Hong YY, Shou CH, Yang WL, Wang XD, Zhang Q, Liu XS, Yu JR. FGFR2 fusions as novel oncogenic drivers in gastrointestinal stromal tumors: Two case reports and review of literature. World J Gastrointest Oncol 2025; 17(11): 113262
6
"I read with interest of this article. In spite of there are many similar studies in literature, the findings of this study is still ..."  [Read more]
"I read with interest of this article. In spite of there are many similar studies in literature, the findings of this study is still informative. Shear wave elastography (SWE) is a non-invasive ultrasound (US) technique that can quantify tissue stiffness, which can used for assistance of diagnosing focal and diffusive diseases. Establishing reference values in normal tissues or organs in healthy individuals is crucial, since abnormal stiffness is associated with clinically relevant conditions such as tumors, liver fibrosis, and pancreatic disease. In the literature, normal values of stiffness for liver, spleen, and pancreas in healthy individuals are various, and they have not been well established. In this study, the investigators measured the stiffness of the liver, spleen, and pancreas in 50 healthy subjects with p-QElaXto and 2D-QElaXto on Esaote MyLab 9 ultrasound system, compared with 2D-SWE on the SuperSonic Imagine Aixplorer (SSI). Values of measurements of stiffness ranges were analyzed for relationship with clinical and technical factors, and inter-operator variability across the different SWE modalities were studied. The results demonstrated that the liver and spleen stiffness assessment was feasible in > 98% of patients, while pancreas stiffness was measurable in 84%-88% depending on the SWE technique. Mean liver stiffness ranged between 3.9-4.7 kPa across techniques, spleen stiffness ranged from 19.4-23.0 kPa, and pancreas stiffness from 5.2-7.6 kPa. Inter-operator agreement was excellent for liver and good to moderate for spleen and pancreas. Bland-Altman analysis confirmed good correlation but also systematic differences among devices, especially in pancreas measurements. The investigators concluded that the values of stiffness of the liver and spleen matched existing guidelines, and pancreas SWE showed more variability and reduced reproducibility. Stiffness measurements of the pancreatic using shear wave elastography is less reliable than that for liver and spleen. There were some potential limitations of this study, as had been addressed in the article, especially the relatively small sample size compromises the soundness and robust of the results. "  [Collapse]
Viceconti N, Paratore M, Del Zompo F, Zocco MA, Ainora ME, Esposto G, Gasbarrini A, Pompili M, Riccardi L, Garcovich M. Shear wave elastography in healthy patients: Pancreatic stiffness is less reliable than liver and spleen measurements. World J Radiol 2025; 17(11): 111651
7
"This review was well written. The subject was meaningful. The objective of this study was to analyse the utility of point-of-care ..."  [Read more]
"This review was well written. The subject was meaningful. The objective of this study was to analyse the utility of point-of-care ultrasound-measured optic nerve sheath diameter for early identification of raised intracranial pressure in non-traumatic headache patients, aiming to guide clinicians in integrating this technique into early headache evaluation for better patient outcomes. Point-of-care ultrasound measurement of optic nerve sheath diameter is a convenient, non-invasive method with high sensitivity and specificity for detecting elevated intracranial pressure. Its use can expedite diagnosis, guide urgent management, and reduce unnecessary imaging, especially in outpatient and resource-limited settings. To ensure reliability and accuracy of measurement, comprehensive training programs and standardized protocols for ultrasound operator are required. Emerging artificial intelligence(AI)-assisted measurement promises to enhance its reliability by reducing operator-dependent variability, and this will broaden its clinical impact. AI-assisted interpretation and automated measurement tools will be the future direction. One thing must mention, the word “decline” in the sentence that “A good example of the potential value of POCUS is a patient with an acute neurological decline” should be “deficit”."  [Collapse]
Tlaiss Y, Tarchichi A, Atallah K, Al Mashtoub E, Zalzali I, Chokor Z, Fassih I, Harb N, Kassas J, Hamze H. Point-of-care ultrasonography for detecting raised intracranial pressure through optic nerve sheath diameter in non-traumatic headache patients. World J Radiol 2025; 17(11): 113012
8
"In patients with troponin elevation at ER, distinguishing ACS is crucial, but troponin often rises for reasons other than ACS. PSVT ..."  [Read more]
"In patients with troponin elevation at ER, distinguishing ACS is crucial, but troponin often rises for reasons other than ACS. PSVT is one such cause, but diagnosis is difficult if the episode has already terminated by the time the ER ECG is taken. This is because troponin is only positive in 30-50% of PSVT cases. Even if sinus rhythm is present at presentation, troponin may still be positive after PSVT has stopped. For example, in patients who experienced palpitations. Therefore, I would also like to see criteria indicating in which PSVT cases troponin will be positive. Elevated troponin due to paroxysmal supraventricular tachycardia (PSVT) does not merely indicate the presence of ischemic heart disease. It is associated with a high heart rate, prolonged duration, chest pain, and in many cases, causes mild to moderate transient troponin elevation. Conversely, in the absence of obvious organic heart disease, it does not directly correlate with worsened clinical prognosis. The degree of troponin elevation is primarily associated with the heart rate during the episode (risk increases at 165 bpm or higher) and the duration of the episode. Particularly in clinically stable cases, there appears to be limited justification for invasive evaluation based solely on troponin elevation. Further validation through large-scale prospective studies is desired in the future. "  [Collapse]
Özlek B, Tanık VO, Barutçu S. Troponin elevation in supraventricular tachycardia: A narrative review. World J Cardiol 2025; 17(11): 113411
9
"Lymphangiomas occur in various parts of the body, most commonly in the head and neck region, but rarely in the gastrointestinal tract. ..."  [Read more]
"Lymphangiomas occur in various parts of the body, most commonly in the head and neck region, but rarely in the gastrointestinal tract. Esophageal lymphangioma is an exceedingly rare benign submucosal tumor. Lymphangiomas are usually asymptomatic and incidentally found on endoscopic evaluation. This is a well- written and presented rarely case report. This manuscript gives additional new knowledge to the existing literature. Ithink that this manuscript is worth to publication."  [Collapse]
Zheng XL, Yu XX. Esophageal lymphangioma: A case report and review of literature. World J Gastrointest Surg 2025; 17(11): 111148
10
"This study proposes that the tumor-suppressive functions of these proteases are contingent upon the stage of cancer progression or ..."  [Read more]
"This study proposes that the tumor-suppressive functions of these proteases are contingent upon the stage of cancer progression or metastatic conditions, and may be activated or suppressed in response to cues from the tumor microenvironment. The proposition that the functional role of tumors—either promoting or inhibiting cancer—can be dynamically regulated by the tumor microenvironment is a noteworthy conceptual advancement. Indeed, cancer is increasingly recognized as a complex pathological ecosystem. Within this framework, genes and mutations are not primary causal drivers of carcinogenesis—as posited by the prevailing somatic mutation theory—but rather represent one of many events occurring throughout tumor evolution. A more comprehensive understanding therefore requires the integration of genetic and mutational dynamics within broader ecological and evolutionary contexts (https://pubmed.ncbi.nlm.nih.gov/40443342/)."  [Collapse]
Palacios Serrato EG, Medina-Abreu KH, Oropeza-Martínez E, Jacinto-Alemán LF, Macías-Silva M, Tecalco-Cruz AC. ADAMTS-8 and kallikrein-related peptidases 10 and 5 proteases also have a tumor suppression role. World J Clin Oncol 2025; 16(11): 110202
11
"• This is very interesting paper about pancreatic cyst. Pancreatic cysts are diagnosed through imaging tests like CT, MRI, and ..."  [Read more]
"• This is very interesting paper about pancreatic cyst. Pancreatic cysts are diagnosed through imaging tests like CT, MRI, and endoscopic ultrasound (EUS). These tests help characterize the cyst's size, structure, and relationship to the pancreas. An EUS can also be used to collect fluid or tissue samples for lab analysis to check for cancer cells, while other factors like symptoms, patient history, and risk factors are also considered to make a final diagnosis. Fluid and tissue analysis: If a sample is collected through EUS-FNA, the fluid is analyzed for specific markers like carcinoembryonic antigen (CEA), which can help identify cancer. The diagnostic process involves a combination of medical history review, various imaging tests, and sometimes fluid analysis/biopsy to determine the cyst's type and its potential for malignancy. "  [Collapse]
Shumka N, Karagyozov PI. Cystic tumors of the pancreas: Current perspectives on diagnosis and management. World J Gastroenterol 2025; 31(43): 111393
12
"The article is well written and well conducted. I particularly appreciated the discussion, which is rich and full of interesting ..."  [Read more]
"The article is well written and well conducted. I particularly appreciated the discussion, which is rich and full of interesting comments. Unfortunately, the study is retrospective. The addition of other parameters, such as the precence of left ventricular noncompaction and serum electrolyte values, would likely have further differentiated the two populations studied."  [Collapse]
Kaddoura R, Al-Tamimi H, Pieles GE. Racial disparities in electrical and structural cardiac adaptation among adolescent athletes: A systematic review and meta-analysis. World J Cardiol 2025; 17(11): 107835
13
" The manuscript is written well. Its structure is appropriate for this type of article. Ethical approval form meets the requirements. ..."  [Read more]
" The manuscript is written well. Its structure is appropriate for this type of article. Ethical approval form meets the requirements. Methods are appropriate and effective. Results are appropriate of methods and are authentic. Tables and biostatistics data are perfect. The references are adequate of topic. Language of article is satisfied."  [Collapse]
Park YE. Gastric Crohn’s disease presenting as a subepithelial tumor: A case report. World J Clin Cases 2025; 13(33): 113312
14
" The manuscript is written well. Its structure is appropriate for this type of article. Ethical approval form meets the requirements. ..."  [Read more]
" The manuscript is written well. Its structure is appropriate for this type of article. Ethical approval form meets the requirements. Methods are appropriate and effective. Results are appropriate of methods and are authentic. Tables and biostatistics data are perfect. The references are adequate of topic. Language of article is satisfied."  [Collapse]
Bergeron E, Gologan A. Abdominal compartment syndrome with colonic hypoganglionosis and massive colonic distension in a young adult: A case report. World J Clin Cases 2025; 13(33): 112684
15
"1. Ethics It is a review article thus ethics approval form is not required 2. Methods As a narrative/invited review, the “methods” ..."  [Read more]
"1. Ethics It is a review article thus ethics approval form is not required 2. Methods As a narrative/invited review, the “methods” section is not a detailed primary experimental protocol. The paper describes construction methods of gastric organoids, modeling steps, mechanisms, limitations and future directions. The methods are adequate in describing the topic and background rather than reporting new experimental workflows. 3. Results The results are summary of published work rather than original data. The authors summaries how gastric organoids can model atrophic gastritis → intestinal metaplasia → dysplasia → gastric cancer, and discuss mechanisms and propose that gastric organoids are a “promising model” for the inflammation-cancer transition. 4. Figures and Tables Figures shows the multiple schematic figures. Annotation/Quality of the figures is good and are schematic exhibiting the appropriateness for this study. The legends appear clear; axes/labels in the schematics are present. The paper has well-constructed and expressive figures and tables. 5. Biostatistics This is a review paper, there is no new statistical analyses/biostatistical tables of primary data are needed. 6. References Lis of references is current, appropriate and is reasonable in number (> 100) 7. Language The language is clear, rationally concise, and generally well-written. "  [Collapse]
Liu C, Wu CH, Jia YB, Qiu JX, Li XY, Ling JH. Gastric organoids: A promising model for studying “inflammation-cancer” transition in atrophic gastritis. World J Clin Oncol 2025; 16(11): 110453
16
"It was with pleasure that I tracked the article quality of the following manuscript. Please see my comments below: 1 Ethics: Not ..."  [Read more]
"It was with pleasure that I tracked the article quality of the following manuscript. Please see my comments below: 1 Ethics: Not applicable given manuscript type 2 Methods: Not applicable given manuscript type 3 Results: Not applicable given manuscript type 4 Figures and tables: The figures add to the readability of the manuscript 5 Biostatistics: Not applicable given manuscript type 6 References: The references are appropriate/up-to-date 7 Language: This is a concise/well written editorial 8 Caveats or drawbacks: N/A "  [Collapse]
Zerem E, Zerem D, Vila Š, Bajgorić S. Ascites in acute pancreatitis: A window into disease severity. World J Gastroenterol 2025; 31(43): 112797
17
"“Pyroptosis” is a term composed of the union of two separate ancient Greek words, namely “Πυρ” (Fire) and “Πτώσις” (fall), which ..."  [Read more]
"“Pyroptosis” is a term composed of the union of two separate ancient Greek words, namely “Πυρ” (Fire) and “Πτώσις” (fall), which together mean “fall of the fire” (reduction of inflammation). It is a lytic mechanism of programmed cell death that involves cleavage of proteins in the gasdermin D family. Its effects are mediated through nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3)/caspase-1 classical and caspase-4/5/11. The inflammatory process mediated by this mechanism appears to play a central role in the development and pathogenesis of IBD by destroying the intestinal epithelial barrier, leading to excessive inflammation and worsening the disease progression. Targeting pyroptosis is a promising therapeutic approach for IBD. Recent data support the notion that inhibitors of inflammasomes, such as small-molecule biological agents, other biological agents, and drugs that specifically target NLRP3, caspases, or GSDMD, suppress inflammasome activation and inhibit membrane pore formation. However, the precise regulatory mechanisms and therapeutic effect of pharmacological targeting of inflammasomes in IBD are not fully understood. Research on the specificity of pharmaceutical agents that may prove effective in treating the disease, the extent of drug side effects, and the potential for combination with other active pharmaceutical agents is a key goal for the near future. "  [Collapse]
Dong WW, Liu T, He LX, He WT. Targeting pyroptosis in inflammatory bowel disease: A potentially effective therapeutic approach. World J Gastroenterol 2025; 31(43): 111358
18
"This letter to the Editor just agrees with the authors of the original paper that BMI is associated with worse outcome in patients ..."  [Read more]
"This letter to the Editor just agrees with the authors of the original paper that BMI is associated with worse outcome in patients with acute liver injury. In this regard, all "scientific" information descries only "associations" with BMI and organ failure. However no studies indicate possible causes so science can advance towards possible treatments beyond weight loss."  [Collapse]
Kanda T, Sasaki-Tanaka R, Kamimura H, Terai S. Is higher body mass index correlated with worse clinical outcomes in acute liver failure? World J Clin Cases 2025; 13(32): 113514
19
"A concise, comprehensive, complex and well-structured manuscript. There are no grammatical/spelling errors throughout the manuscript ..."  [Read more]
"A concise, comprehensive, complex and well-structured manuscript. There are no grammatical/spelling errors throughout the manuscript and the topic debated is of a great interest due to the fact that AI technologies have a real potential to revolutionize liver lesion assessment in association with CEUS. Indeed, in order to obtain a valid implementation in clinical practice of AI technologies combined with CEUS, we need more large-scale prospective studies in the near future. "  [Collapse]
Ciocalteu A, Urhut CM, Streba CT, Kamal A, Mamuleanu M, Sandulescu LD. Artificial intelligence in contrast enhanced ultrasound: A new era for liver lesion assessment. World J Gastroenterol 2025; 31(42): 112196
20
"1 Ethics: Not provided 2 Methods: The experimental method is effective and can be repeated by fellow researchers 3 Results ..."  [Read more]
"1 Ethics: Not provided 2 Methods: The experimental method is effective and can be repeated by fellow researchers 3 Results The theory is validated 4 No figures or tables provided 5 Biostatistics: Not needed 6 References: The author scientifically and reasonably cite the latest references 7 Language: The language in article correctly, clearly and concisely expresses the information "  [Collapse]
Sameer M, Muthu S, Vadranapu S. Prophylactic fixation in elderly fractures: Preventive breakthrough or unnecessary intervention? World J Orthop 2025; 16(11): 109855
15861 items  Read more >>
Peer-Reviewers and Manuscript Statistics
Editorial board members
2264
Peer-reviewers
34938
Manuscripts received today
11
Manuscript reviews today
23
Unhandled manuscripts today
146
Active peer-reviewers today
1985
Reviewer acceptance today
34
Reviewer refusals today
37
Total accepted manuscripts
38920
Total rejected manuscripts
43893
Total peer-reviewers
4541603
Total submissions
36953
Baishideng Publishing Group (BPG) publishes 47 peer-reviewed, open-access journals covering a broad range of topics in clinical medicine, as well as several topics in biochemistry and molecular biology, relevant to human health today.
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Sign In
  • BPG Management System
  • F6Publishing-Submit a Manuscript
  • F6Publishing-世界华人消化杂志在线投稿
  • RCA Management System
English
  • English
  • 简体中文
BPG Journals
Reference Citation Analysis
  • Find an Article (57352687)
  • Find an Article PDF (5719321)
  • Today's Articles (2757)
  • Find a Category (128)
  • Find a Journal (7880)
  • Find a Scholar (4459)
  • Find an Academic Assistant (52)
  • Subscribe (331)
BPG E-Books
BPG Blog
All Journal Articles
1

Liau JYJ, Shelat VG. Evolving ethos of medical research: A retrospective analysis of the declaration of Helsinki (1964-2024). World J Methodol 2025; 15(4): 107699

2025-12-20 | Browse: 5661 | Download: 335
2

English K, Uwibambe C, Daniels P, Dzukey E. Scoping review of micronutrient imbalances, clinical manifestations, and interventions. World J Methodol 2025; 15(4): 107664

2025-12-20 | Browse: 5919 | Download: 497
3

Hafez MM, Bahcecioglu IH, Yalniz M, Kouta KA, Tawheed A. Future of inflammatory bowel disease treatment: A review of novel treatments beyond guidelines. World J Methodol 2025; 15(4): 107643

2025-12-20 | Browse: 6831 | Download: 519
4

Hu HF. Research on the high quality innovative development model of "Chain + virtual elderly care" services in Hengyang city based. World J Methodol 2025; 15(4): 107503

2025-12-20 | Browse: 4576 | Download: 321
5

Vempati R, Damarlapally N, Vasudevan SS, Patel V, Banda P, Mourad D, Polamarasetty H, Mathur G, Khan A, Desai R, Ratnani I, Surani S. Association of neutrophil-lymphocyte ratio with cardiovascular and all-cause mortality in patients receiving chronic hemodialysis: Systematic review and meta-analysis. World J Methodol 2025; 15(4): 107468

2025-12-20 | Browse: 5284 | Download: 374
6

Abdulrasak M, Ahmed M, Hootak S. Utility of splenic transient elastography in assessing for the presence of portal hypertension: A review. World J Methodol 2025; 15(4): 107411

2025-12-20 | Browse: 4983 | Download: 343
7

Okasha HH, Gadour E, Alyouzbaki AZ, Shaaban HE. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic tumors: Current status and future perspectives. World J Methodol 2025; 15(4): 107305

2025-12-20 | Browse: 5602 | Download: 346
8

Kaur R, Morya AK, Gupta PC, Aggarwal S, Menia NK, Kaur A, Kaur S, Sinha S. Artificial intelligence-based apps for screening and diagnosing diabetic retinopathy and common ocular disorders. World J Methodol 2025; 15(4): 107166

2025-12-20 | Browse: 5857 | Download: 439
9

Metin İ, Özdemir Ö. Artificial intelligence in medicine: Current applications in cardiology, oncology and radiology: A mini review. World J Methodol 2025; 15(4): 106854

2025-12-20 | Browse: 5340 | Download: 394
10

Lucero CM, Luco JB, Albani Forneris A, Buttaro MA. Recurrent femoral stem fractures in Dorr A femurs: Lessons learned and a call for alternative strategies. World J Methodol 2025; 15(4): 106708

2025-12-20 | Browse: 4443 | Download: 303
11

Solstad TU, Mucha AW, Olsen AA, Grossjohann H, Achiam MP. Preoperative marking of the proximal resection margin in esophageal cancer with a surgical fiducial marker-first experiences. World J Methodol 2025; 15(4): 106591

2025-12-20 | Browse: 4939 | Download: 428
12

Stamiris S, Cheva A, Potoupnis M, Anestiadou E, Stamiris D, Bekiari C, Loukousia A, Kyriakos P, Tsiridis E, Sarris I. Effect of alpha-tocopherol and OTR-4131 on muscle degeneration after rotator cuff tear in rats: An experimental protocol. World J Methodol 2025; 15(4): 106216

2025-12-20 | Browse: 4599 | Download: 401
13

Singh JP, Aleissa M, Chitragari G, Drelichman ER, Mittal VK, Bhullar JS. Uncovering the role of microbiota and fecal microbiota transplantation in Crohn’s disease: Current advances and future hurdles. World J Methodol 2025; 15(4): 106148

2025-12-20 | Browse: 4710 | Download: 310
14

Xu DJ, Zhong Q, Wang GT, Lu X. Preventive and therapeutic effects of magnesium sulfate on nikethamide-induced seizures: Implications for COVID-19 treatment. World J Methodol 2025; 15(4): 105775

2025-12-20 | Browse: 5133 | Download: 403
15

Das N, Gade KR, Addanki PK. Artificial intelligence for early diagnosis and risk prediction of periodontal-systemic interactions: Clinical utility and future directions. World J Methodol 2025; 15(4): 105516

2025-12-20 | Browse: 5390 | Download: 410
16

Musbahi O, Pouris K, Hadjixenophontos S, Al-Saadawi A, Soteriou I, Cobb JP, Jones GG. Machine learning for patient selection in corticosteroid decision making in knee osteoarthritis: A feasibility model. World J Methodol 2025; 15(4): 105493

2025-12-20 | Browse: 4832 | Download: 434
17

Kamrul-Hasan ABM, Pappachan JM, Ashraf H, Nagendra L, Dutta D, Kuchay MS, Shaikh S. Safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with type 2 diabetes mellitus fasting during Ramadan: a systematic review and meta-analysis. World J Methodol 2025; 15(4): 105478

2025-12-20 | Browse: 5299 | Download: 375
18

Cigrovski Berkovic M, Cigrovski V, Ruzic L. Role of irisin in physical activity, sarcopenia-associated type 2 diabetes, and cardiovascular complications. World J Methodol 2025; 15(4): 105462

2025-12-20 | Browse: 4828 | Download: 382
19

Jain A, Kaushal A, Kumar H, Karna ST, Ahmad Z, Trivedi S. Analgesic efficacy of continuous ultrasound-guided unilateral erector-spinae block and thoracic epidural in patients undergoing antero-lateral thoracotomy. World J Methodol 2025; 15(4): 105386

2025-12-20 | Browse: 4879 | Download: 373
20

Ardila CM. Advancing dental precision: The synergy of magnification and artificial intelligence. World J Methodol 2025; 15(4): 105326

2025-12-20 | Browse: 4316 | Download: 296
61158 items  Read more >>
Featured Articles
1

Wang J, Chang L, Niu DF, Yan Y, Cao CQ, Li SJ, Wu Q. Diagnostic accuracy of stereomicroscopy assessment of invasion depth in ex vivo specimens of early gastric cancer. World J Gastroenterol 2025; 31(45): 112518

2025-12-03 | Browse: 10 | Download: 16
2

Lei ZL, Tan ZL, Luo YH, Yang M, Wang JL, Qin Z, Liu YY. Comparison of the efficacy of laparoscopic hepatectomy and radiofrequency ablation for small hepatocellular carcinoma: A retrospective study. World J Gastroenterol 2025; 31(45): 111540

2025-12-03 | Browse: 6 | Download: 42
3

Ma HF, Chen YH, Wang Y, Zhang XC, Li JN, Wang YM, Zhou ZY. Complete blood counts and their derived inflammatory markers with anal fistulas in male children: A retrospective case-control study. World J Gastroenterol 2025; 31(45): 112926

2025-12-03 | Browse: 7 | Download: 39
4

Xu JH, Liu Y. Organ preservation in esophageal cancer treatment, is it time now? World J Gastroenterol 2025; 31(45): 112287

2025-12-03 | Browse: 7 | Download: 35
5

Yang D, Kim B, Kim JW. Mechanistic insights into hepatic cell type-specific contributions to acetaminophen-induced acute liver injury. World J Gastroenterol 2025; 31(45): 112720

2025-12-03 | Browse: 7 | Download: 36
6

Zeppieri M, Musa M, Cordeiro MF, Gagliano C, D’Esposito F. Reevaluating Usher syndrome: Transitioning from traditional subtypes to precision diagnosis. World J Med Genet 2025; 13(1): 112991

2025-12-01 | Browse: 17 | Download: 29
7

Elaiopoulos D, Dimitriadis F, Tzatzaki E, Chronaki M, Kolonia K, Antonopoulos M, Konstantinou G, Kogerakis N, Dimopoulos S. Vasopressin role in hypertrophic obstructive cardiomyopathy post-cardiac surgery: A case report. World J Crit Care Med 2025; 14(4): 106485

2025-11-28 | Browse: 42 | Download: 102
8

Khan SA, Moeed A, Mari T, Yousuf Z, Hanson A, Dong Y, Cornelius P, Anjum H, Ratnani I, Surani S. Safety and early mobilization in intensive care unit patients: An updated systematic review and meta-analysis of randomized controlled trials. World J Crit Care Med 2025; 14(4): 107396

2025-11-28 | Browse: 45 | Download: 93
9

Thoppil J, Farrar JD, Sharma D, Kirby S, Mobley A, Courtney DM. Reactive oxygen species elevations in human immune cell subsets during sepsis are mitigated by norepinephrine and N-acetylcysteine. World J Crit Care Med 2025; 14(4): 108638

2025-11-28 | Browse: 33 | Download: 89
10

Eltahir M, Fawzy I, Ibrahim AS, Ibrahim EA, Mazhar R, Shallik NA, El-Menyar A, Shehatta AL. Extracorporeal membrane oxygenation support in patients with difficult airway management: Case series of 13 patients. World J Crit Care Med 2025; 14(4): 106027

2025-11-28 | Browse: 38 | Download: 98
11

El-Menyar A, Khan NA, Elmenyar E, Cander B, Szarpak L, Krishnan S V, Galwnkar S, Al-Thani H. Thyroid storm-induced cardiovascular complications and modalities of therapy: Up-to-date review. World J Crit Care Med 2025; 14(4): 109565

2025-11-28 | Browse: 38 | Download: 77
12

Taskiran I, Orenay-Boyacioglu S, Boyacioglu O, Erdogdu IH, Culhaci N, Meteoglu I. DNA polymerase epsilon-mutant colorectal cancers: Insights into non-exonuclease domain mutation variants, microsatellite instability status, and co-mutation profiles. World J Gastroenterol 2025; 31(44): 112524

2025-11-28 | Browse: 51 | Download: 92
13

Fu YC, Li J, Wang JY, Zhang YW, Yan F, Chen J, Du Q, Yang C, Liang J, Ye Q, Xiang HL. Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B. World J Gastroenterol 2025; 31(44): 112719

2025-11-28 | Browse: 36 | Download: 128
14

Feng YF, Su TM, Hu BB, Wang H, Li QM, Yin QB, Huang L, Liang HQ, Ren AL, Su MH, Jiang JN. Diagnostic performance of serum origin recognition complex subunit 1 protein for hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2025; 31(44): 112481

2025-11-28 | Browse: 39 | Download: 111
15

Liu YZ, Liu WX, Deng WH. Advances in the study of the relationship between neurotransmitters and gastric cancer. World J Gastroenterol 2025; 31(44): 113793

2025-11-28 | Browse: 35 | Download: 87
16

Zheng L, Duan SL. Neuroimmune interactions in inflammatory bowel disease: Role of intestinal macrophages and the cholinergic pathway. World J Gastroenterol 2025; 31(44): 109440

2025-11-28 | Browse: 37 | Download: 80
17

Kabadayi Sahin E. Lithium and valproic acid in bipolar disorder: Beyond mood stabilization, the overlooked role of sleep. World J Psychiatry 2025; 15(12): 113893

2025-11-27 | Browse: 48 | Download: 94
18

Xie LD, Wu JP, Liu SS, Zong Z, Hu Y, Ling N, Han B, Li WL, Yao HY. Investigating the pharmaceutical substances and action mechanisms of Changmaxifeng granules against tic disorders. World J Psychiatry 2025; 15(12): 112055

2025-11-27 | Browse: 43 | Download: 119
19

Ma J, Xu H, Yang B, Han X, Chen Q, He XY, Qiao CP. Construction of a psychological intervention program to support fear of recurrence in patients with cervical cancer. World J Psychiatry 2025; 15(12): 112651

2025-11-27 | Browse: 43 | Download: 130
20

Sarac E, Odabas D. Economic abuse as a woman battering form: A cross-sectional study among physicians and nurses. World J Psychiatry 2025; 15(12): 111334

2025-11-27 | Browse: 41 | Download: 122
10146 items  Read more >>
Keyword Search Published Articles Processes
1
Case report
2854
2
Case report
1831
3
Hepatocellular carcinoma
1472
4
Gastric cancer
1040
5
Colorectal cancer
1016
6
Inflammatory bowel disease
729
7
COVID-19
709
8
Prognosis
671
9
Liver transplantation
634
10
Ulcerative colitis
563
11
Treatment
552
12
Helicobacter pylori
525
13
Crohn’s disease
522
14
Diagnosis
517
15
Endoscopy
482
16
Cirrhosis
481
17
Meta-analysis
455
18
Pancreatic cancer
451
19
Magnetic resonance imaging
441
20
Surgery
424
73839 items  Read more >>
Reader Comments
1
"The editorial authored by Watanabe presents a timely and clinically pertinent overview of lisocabtagene maraleucel (liso-cel) CAR-T ..."  [Read more]
"The editorial authored by Watanabe presents a timely and clinically pertinent overview of lisocabtagene maraleucel (liso-cel) CAR-T therapy, specifically addressing nodal and gastrointestinal follicular lymphoma (GI-FL). The author skillfully amalgamates essential findings from the TRANSCEND FL trial, emphasizing the extraordinary 97% overall response rate and a 94% complete response rate, alongside a notably reduced toxicity profile where grade ≥3 cytokine release syndrome (CRS) was absent, and grade ≥3 neurotoxicity was observed in merely 3% of patients. This concentrated analysis on the unique advantages of liso-cel—particularly its defined CD4+/CD8+ composition and the feasibility of outpatient treatment—addresses a significant void in the existing literature, especially in light of the historical exclusion of GI-FL from crucial CAR-T trials. The comparative framework juxtaposing lisocabtagene maraleucel with axicabtagene ciloleucel and tisagenlecleucel provides invaluable insights for clinical decision-making. Nevertheless, the editorial's otherwise robust examination fails to explore subtleties regarding the durability of response in high-risk subpopulations. Although the reported 12-month progression-free survival rate exceeding 85% is promising, emerging data indicate that follicular lymphoma patients with specific genomic alterations (e.g., TP53 mutations or 1p36 deletions) display varied responsiveness to CAR-T therapy. This omission is particularly salient for GI-FL, where the biological characteristics of the disease may diverge from those of nodal FL due to influences from the microenvironment. Furthermore, the editorial rightly recognizes cost as a barrier but insufficiently emphasizes how the manufacturing logistics of Liso-Cel disproportionately hinder accessibility in advanced GI-FL cases. Unlike nodal FL, where treatment delays may be manageable, GI-FL frequently presents urgent complications necessitating swift intervention. The three-week manufacturing timeline for liso-cel—despite improvements over previous platforms—remains a challenge for these patients, a difficulty exacerbated by the absence of validated bridging strategies tailored to gastrointestinal involvement. Looking ahead, the integration of endoscopic and molecular staging systems (e.g., Paris classification) with CAR-T therapy response biomarkers emerges as a critical research priority. Real-world studies should specifically investigate GI-FL cohorts to ascertain whether mucosal disease localization influences CAR-T trafficking or persistence. Additionally, the formulation of risk-adapted conditioning regimens could optimize the therapeutic index in patients with gastrointestinal involvement, where organ-specific toxicities remain inadequately characterized. Watanabe's appeal for multicenter collaboration should explicitly encompass these mechanistic and health-services research inquiries to propel personalized CAR-T applications across follicular lymphoma subtypes. "  [Collapse]
Watanabe T. Emerging role of lisocabtagene maraleucel chimeric antigen receptor-T cell in nodal and gastrointestinal follicular lymphoma. World J Gastroenterol 2025; 31(45): 112336
2
"This review elevates our understanding of acetaminophen (APAP)-induced acute liver injury from a “single toxic metabolite acting on ..."  [Read more]
"This review elevates our understanding of acetaminophen (APAP)-induced acute liver injury from a “single toxic metabolite acting on hepatocytes” model to a dynamic network involving multiple hepatic cell populations. Second, it clearly maps out current and potential therapeutic targets, essentially providing a “cell-type–oriented treatment roadmap” for future translational work. The discussion of CYP2E1/CYP3A4, species differences, and risk factors (such as alcohol use, malnutrition, underlying liver disease, and concomitant enzyme-inducing drugs) helps clinicians better identify high-risk populations and appreciate the limitations of extrapolating from animal models, thereby supporting more individualized risk assessment and dosing. In the treatment section, the authors extend beyond the classical “N-acetylcysteine golden window” and cover emerging strategies such as inhibition of NAPQI formation (e.g. fomepizole), mitochondria-targeted antioxidants (Mito-Tempo, MitoQ), modulation of ferroptosis/ferritinophagy, NLRP3–STING inflammasome pathways, as well as cell-based and hepatocyte transplantation therapies. This allows clinical readers to quickly grasp potential combination or alternative approaches that are entering or approaching clinical trials, while signaling to basic scientists multiple promising cellular pathways and targets for deeper exploration. Overall, the article reads as an up-to-date progress review on the multicellular mechanisms and therapeutic targets of APAP-induced acute liver injury, offering both mechanistic clarity and topic inspiration for those working on drug-induced liver injury, emergency/critical care, and liver transplantation—while also realistically emphasizing that most of the evidence remains at the experimental or early translational stage and is not yet ready to change clinical guidelines. "  [Collapse]
Yang D, Kim B, Kim JW. Mechanistic insights into hepatic cell type-specific contributions to acetaminophen-induced acute liver injury. World J Gastroenterol 2025; 31(45): 112720
3
"this review provides a clear and systematic overview of the interactions among intestinal macrophages, the enteric nervous system, ..."  [Read more]
"this review provides a clear and systematic overview of the interactions among intestinal macrophages, the enteric nervous system, and the cholinergic anti-inflammatory pathway in inflammatory bowel disease (IBD). By closely linking basic mechanistic insights with the potential clinical application of vagus nerve stimulation (VNS)—especially low-frequency, non-invasive VNS—the paper offers a fresh “neuroregulation–immune modulation” angle on IBD treatment, which is currently dominated by immunosuppressants and biologics. In terms of clinical practicality, the authors emphasize the promise of non-invasive VNS as a safer and more tolerable approach, while frankly acknowledging that current evidence still largely comes from animal models and a few pilot clinical studies, with a lack of large-scale randomized controlled trials. This “promising yet cautious” tone is valuable for clinical readers. On the one hand, the paper helps gastroenterologists and basic scientists understand why heart rate variability (HRV), emotional status, and autonomic imbalance may be linked to IBD course and relapse; on the other hand, it reminds readers that VNS and α7nAChR-targeted agents are still at the stages of proof-of-concept and early translation. In the short term, their main value lies in inspiring new research designs (for example, clinical trials stratified by HRV, combined with intestinal macrophage phenotype analysis), rather than immediately changing standard treatment pathways. Overall, this work reads like a forward-looking “blueprint” for neuro-immune therapies in IBD and is particularly thought-provoking for readers interested in IBD mechanisms and novel therapeutic strategies. "  [Collapse]
Zheng L, Duan SL. Neuroimmune interactions in inflammatory bowel disease: Role of intestinal macrophages and the cholinergic pathway. World J Gastroenterol 2025; 31(44): 109440
4
"A central strength of the study is its large sample size (n = 854) and decade-long retrospective evaluation, which supports the ..."  [Read more]
"A central strength of the study is its large sample size (n = 854) and decade-long retrospective evaluation, which supports the robustness of the findings. Notably, the study highlights a high interobserver and intraobserver agreement (κ > 0.80), underscoring stereomicroscopy’s potential for reproducible clinical application—a crucial factor for methods proposed to bridge endoscopy and pathology. The authors also address an important real-world problem: tissue loss and underestimation of invasion depth during routine histologic sectioning. By guiding the selection of cutting planes, stereomicroscopy shows a remarkable 93.3% accuracy in pinpointing the deepest invasion point in confirmed pT1b lesions. This practical benefit may directly reduce false-negative diagnoses and inconsistent sampling. Furthermore, the identification of basal vessel diameter as a quantitative correlate of invasion depth (663.6 μm in pT1b vs 505.5 μm in pT1a) is an innovative contribution. This measurable parameter moves stereomicroscopy beyond subjective interpretation and toward a more standardized diagnostic algorithm. However, as the authors clearly demonstrate, the method’s utility is highly context-dependent. Diagnostic performance deteriorates sharply in ulcerated lesions (accuracy 35.8%), where fibrosis, inflammatory remodeling, and electrocautery artifacts can obscure the true nature of the submucosal planes. This limitation is not trivial: ulceration is common in EGC and often signals biologically aggressive behavior. "  [Collapse]
Wang J, Chang L, Niu DF, Yan Y, Cao CQ, Li SJ, Wu Q. Diagnostic accuracy of stereomicroscopy assessment of invasion depth in ex vivo specimens of early gastric cancer. World J Gastroenterol 2025; 31(45): 112518
5
"Commentary on "Large Language Models and Large Concept Models in Radiology: Present Challenges, Future Directions, and Critical ..."  [Read more]
"Commentary on "Large Language Models and Large Concept Models in Radiology: Present Challenges, Future Directions, and Critical Perspectives" The transition from LLMs to LCMs, aiming for enhanced semantic reasoning, is fundamentally challenged by the necessity of building these sophisticated models upon historical data streams polluted by human cognitive biases [1]. Diagnostic interpretation errors are often not perceptual misses but interpretive errors driven by faulty reasoning [2,3]. These biases include Anchoring Bias, where a radiologist becomes fixated on an initial impression despite contradictory evidence, often coupled with Confirmation Bias, the inclination to seek information only to affirm that initial theory [2,4,5]. Similarly, Availability Bias, or availability heuristics, predisposes the interpreter to recall recently seen or memorable diagnoses regardless of the actual prevalence [3,4,6]. When AI learns its "concepts" or "relationships" from millions of reports generated under the influence of these specific biases, it may normalize or amplify flawed reasoning patterns, potentially leading to widespread, systemic diagnostic vulnerabilities that mirror rather than correct human limitations [3]. For instance, an AI trained primarily on reports that exhibit Zebra Retreat—the avoidance of accurate but rare diagnoses due to lack of confidence—will systematically underreport uncommon but critical findings, reducing the diagnostic sensitivity for edge cases [2,6]. The core strength of future AI systems must therefore lie not just in conceptual depth but in active debiasing, mitigating the human errors that underpin the training corpus [4,5]. If AI recommendations are opaque, clinicians may fall prey to Blind Obedience or Premature Closure by accepting the machine's initial diagnosis without critical Type 2 analysis [2,6]. To counter this, AI must incorporate the same cognitive forcing strategies used by human interpreters, demanding metacognition ("thinking about thinking") to identify susceptibility to bias [3,4]. Furthermore, AI must specifically address the Hindsight Bias that plagues retrospective quality review [2,6], by ensuring its decision pathways are fully auditable and transparent, allowing for objective assessment of whether an error resulted from inherent data contamination or algorithmic failure. As AI integrates deeper into clinical workflows, its ability to enhance safety hinges on proactively resisting the transfer and propagation of predictable human cognitive limitations [6]. References 1. Merchant SA, Merchant N, Varghese SL, Shaikh MJS. Large language models and large concept models in radiology: Present challenges, future directions, and critical perspectives. World J Radiol. 2025;17(11):114754. [DOI: 10.4329/wjr.v17.i11.114754] 2. Onder O, Yarasir Y, Azizova A, Durhan G, Onur MR, Ariyurek OM. Errors, discrepancies and underlying bias in radiology with case examples: a pictorial review. Insights Imaging. 2021;12:51. [PMID: 33877458. DOI: 10.1186/s13244-021-00986-8] 3. Chen J, Gandomkar Z, Reed WM. Investigating the impact of cognitive biases in radiologists' image interpretation: A scoping review. Eur J Radiol. 2023;166:111013. [PMID: 37541180. DOI: 10.1016/j.ejrad.2023.111013] 4. Busby LP, Courtier JL, Glastonbury CM. Bias in Radiology: The How and Why of Misses and Misinterpretations. Radiographics. 2018;38:236–247. [PMID: 29194009. DOI: 10.1148/rg.2018170107] 5. Gunderman RB. Biases in radiologic reasoning. AJR Am J Roentgenol. 2009;192:561–564. [PMID: 19234247. DOI: 10.2214/AJR.08.1220] 6. Yoon SY, Lee KS, Bezuidenhout AF, Kruskal JB. Spectrum of Cognitive Biases in Diagnostic Radiology. Radiographics. 2024;44:e230059. [PMID: 38843094. DOI: 10.1148/rg.230059] "  [Collapse]
Merchant SA, Merchant N, Varghese SL, Shaikh MJS. Large language models and large concept models in radiology: Present challenges, future directions, and critical perspectives. World J Radiol 2025; 17(11): 114754
6
"The authors present a clinically important case highlighting the coexistence of mixed connective tissue disease (MCTD) and ..."  [Read more]
"The authors present a clinically important case highlighting the coexistence of mixed connective tissue disease (MCTD) and tuberculosis (TB), a scenario that poses substantial diagnostic challenges in TB-endemic regions. The manuscript is well structured and clearly describes the sequence of clinical events, laboratory workup, and therapeutic decisions. The discussion appropriately emphasizes the overlap between autoimmune manifestations and infectious etiologies, particularly when both present with pulmonary involvement. From an academic standpoint, the case is relevant and contributes meaningfully to the limited global literature examining MCTD–TB coexistence. The authors successfully integrate immunological findings with epidemiological considerations, underscoring the need for high clinical suspicion and comprehensive autoimmune evaluation in complex presentations. The reference list is current and well selected, drawing from both rheumatology and infectious disease literature. The language is generally clear and understandable, although a few sections may benefit from stylistic tightening to improve flow, particularly in the discussion where multiple concepts are presented in close succession. Minor grammatical refinements could enhance readability. The inclusion of comprehensive tables and immunological profiles strengthens the diagnostic clarity of the case. For future research and case documentation, the authors may consider: 1. Providing a more detailed longitudinal follow-up, especially regarding TB status, autoimmune markers, and treatment tapering, as long-term outcomes for MCTD-TB coexistence are not well described in the literature. 2. Elaborating on radiologic findings, given the central role of imaging in differentiating pulmonary TB from autoimmune lung involvement. 3. Discussing possible immunopathological links between chronic infections and autoimmune flare, which could enrich the mechanistic understanding of such overlap syndromes. 4. Addressing medication safety monitoring, particularly concerning hepatotoxicity in the context of ATT combined with corticosteroids and hydroxychloroquine. Overall, this is a valuable clinical contribution that highlights key diagnostic considerations in resource-limited, TB-endemic settings. The manuscript is academically sound, clinically relevant, and will be informative for physicians managing complex autoimmune presentations. "  [Collapse]
Sial F, Basit A, Ghafoor N, Sial W, Basil AM. Mixed connective tissue disease and tuberculosis coexistence as a diagnostic dilemma: A case report. World J Clin Cases 2025; 13(33): 109866
7
"The review by Nian et al. offers a thorough and thoughtfully articulated overview of current insights into Osteopontin (OPN)–mediated ..."  [Read more]
"The review by Nian et al. offers a thorough and thoughtfully articulated overview of current insights into Osteopontin (OPN)–mediated PI3K/AKT signaling and its pivotal influence on gastrointestinal cancer progression, metastatic behavior, and therapeutic resistance. The authors skillfully synthesize mechanistic and translational findings, underscoring how OPN-driven activation of the PI3K/AKT pathway promotes epithelial–mesenchymal transition, metabolic adaptation, immune escape, and chemoresistance. Their discussion of OPN splice variants, tumor microenvironment interactions, and biomarker-informed therapeutic strategies provides meaningful guidance for advancing precision oncology. A major strength of the review is its emphasis on the inherent complexity and compensatory nature of OPN–PI3K/AKT signaling, which helps explain the challenges associated with single-agent therapeutic approaches. The recommendation to pursue combination strategies—such as pairing PI3K/AKT inhibitors with immune checkpoint blockade or OPN-targeted antibodies—is timely and supported by accumulating preclinical data. Furthermore, the manuscript’s focus on PIK3CA mutation subsets and OPN expression as potential predictive biomarkers may enable more refined patient stratification in future clinical trials. Despite these promising avenues, clinical translation remains constrained. Current trials evaluating PI3K/AKT inhibitors in gastrointestinal malignancies have yielded limited efficacy and notable toxicity, highlighting the need for more rigorous biomarker-driven study designs. Although the review acknowledges these issues, a deeper appraisal of the reasons underlying clinical shortcomings—and the specific contribution of OPN signaling to these obstacles—would further strengthen its clinical impact. In sum, this review provides a valuable contribution by elucidating the diverse oncogenic roles of OPN and outlining strategic paths toward overcoming therapeutic resistance. Continued research into isoform-specific activity, tumor microenvironmental dynamics, and rational combinatorial regimens will be crucial for realizing the therapeutic potential of targeting the OPN–PI3K/AKT axis in gastrointestinal cancers. "  [Collapse]
Nian H, Bai Y, Wang HY, Yu H, Zhang ZL, Shi RH, Zhang S, Wu YB, Zhou DH, Du QC. Targeting the Osteopontin-regulated PI3K/AKT signaling pathway: A molecular approach to overcome drug resistance and metastasis in gastrointestinal tumors. World J Gastrointest Oncol 2025; 17(11): 109923
8
"This article presents an interesting retrospective study involving a substantial cohort of patients, highlighting the role of total ..."  [Read more]
"This article presents an interesting retrospective study involving a substantial cohort of patients, highlighting the role of total neoadjuvant therapy (TNT), specifically the RAPIDO protocol, compared to conventional long-course chemoradiotherapy (LCCRT) in the management of locally advanced rectal cancer (LARC). The study focuses on early surgical outcomes, a topic of significant clinical relevance. The cornerstone of LARC treatment remains optimal surgical resection via total mesorectal excision (TME). To reduce locoregional failure, preoperative concurrent chemoradiotherapy has long been the standard of care. However, as noted in the article and supported by prior evidence (e.g., Fokas et al.), the efficacy of this approach is primarily confined to local control, while distant metastases continue to be a major cause of treatment failure and compromised survival. The intensification of neoadjuvant therapy through TNT addresses this limitation by achieving early systemic control, significant tumor downstaging, and higher rates of pathological complete response, all without compromising early surgical outcomes compared to LCCRT, as demonstrated in this study. Moreover, the authors report that TNT is associated with a shorter total stoma duration and a lower permanent stoma rate, which are meaningful benefits for patients' quality of life. Recent landmark trials, such as RAPIDO and PRODIGE 23, have provided robust evidence supporting the use of TNT, showing improved pathological complete response, better treatment compliance, and reduced distant metastases compared to LCCRT. This study adds valuable real-world data to the growing body of literature affirming the safety and feasibility of TNT from a surgical perspective. We commend the authors for their contribution and agree that further prospective studies with longer follow-up are warranted to evaluate long-term oncological outcomes. (By Prof Sanaa El Majjaoui and Pr Nabil Ismaili) "  [Collapse]
Jabbar SAA, Choo ALE, Wong NW, Ngu JCY, Teo NZ. Comparing early surgical outcomes between total neoadjuvant therapy and standard long course chemoradiotherapy for rectal cancer. World J Gastrointest Oncol 2025; 17(11): 111250
9
"This minireview describes the important role of 0steopontin (OPN)-regulated the phosphatidylinositol 3-kinase (PI3K)/protein kinase ..."  [Read more]
"This minireview describes the important role of 0steopontin (OPN)-regulated the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway in gastrointestinal tumor proliferation, metastasis, chemoresistance, and immune evasion. Targeting osteopontin-regulated PI3K/AKT signaling pathway with PI3K/AKT inhibitors or OPN neutralizing antibodies may reverse drug resistance and suppress metastasis. Further research should be needed to find combination therapies which have the potential to provide more effective anti-tumor activity towards refractory cancers. "  [Collapse]
Nian H, Bai Y, Wang HY, Yu H, Zhang ZL, Shi RH, Zhang S, Wu YB, Zhou DH, Du QC. Targeting the Osteopontin-regulated PI3K/AKT signaling pathway: A molecular approach to overcome drug resistance and metastasis in gastrointestinal tumors. World J Gastrointest Oncol 2025; 17(11): 109923
10
"I want to congratulate the authors for conducting this excellent study on the impact of PAD in PEP. This study has demonstrated that ..."  [Read more]
"I want to congratulate the authors for conducting this excellent study on the impact of PAD in PEP. This study has demonstrated that PAD, particularly Type B, has a Significant risk of PEP. This subgroup analysis of PAD is important for advancing efforts to prevent PEP. This study included predominantly older patients, where the prevalence of PAD is higher. Whether the presence of only PAD increases the risk of pancreatitis is still difficult to interpret. As PAD increases the difficulty of CBD cannulation, requiring advanced cannulation techniques which itself may increase the risk of PEP, furthermore indication of ERCP is also analysed in both groups "  [Collapse]
Shu J, Liao YS, Zhang YJ, Zhou WL, Zhang H. Impact of periampullary diverticulum on the incidence of post-endoscopic retrograde cholangiography pancreatitis. World J Gastrointest Endosc 2025; 17(11): 111243
11
"The study by Li Lin et al., “Early vs conventional initiation of adjuvant chemotherapy in advanced gastric cancer: A ..."  [Read more]
"The study by Li Lin et al., “Early vs conventional initiation of adjuvant chemotherapy in advanced gastric cancer: A propensity-matched outcomes study,” addresses a clinically relevant question; however, several issues limit the strength and applicability of its conclusions. First, the analysis does not demonstrate any clear advantage of early versus conventional initiation of adjuvant chemotherapy in terms of either overall survival or disease-free survival. A possible benefit is suggested with respect to the rate of peritoneal recurrence, but this signal is difficult to interpret in the absence of any comparison with currently available intraperitoneal treatment strategies. Moreover, the study does not provide robust selection criteria to clearly identify which patients might be optimal candidates for an earlier initiation of adjuvant therapy. Given the well-known short-term physiological impact of gastrectomy, there is a concrete risk that patients starting chemotherapy very early after surgery may actually receive a suboptimal treatment—most notably through dose reductions—precisely in the first cycles, when dose intensity may be most critical. Finally, the heterogeneity of the adjuvant chemotherapy regimens, which persists even after propensity score matching, further complicates interpretation of the results and limits the ability to draw firm conclusions regarding the true effect of treatment timing per se. "  [Collapse]
Lin L, Zhang P, Wang YY, Cai YF, Wen LB, Chen WP, Xiao YF, Li ZK, Liu GY. Early vs conventional initiation of adjuvant chemotherapy in advanced gastric cancer: A propensity-matched outcomes study. World J Gastroenterol 2025; 31(42): 110069
12
"Long-term prognosis of HBV-cirrhosis hepatocellular carcinoma recurrence and mortality rates post-treatment with antivirals TDF, TAF, ..."  [Read more]
"Long-term prognosis of HBV-cirrhosis hepatocellular carcinoma recurrence and mortality rates post-treatment with antivirals TDF, TAF, ETV and curative radiofrequency ablation is still controversial Dina Johar* Department of Biochemistry and Nutrition, Faculty of Women for Arts, Sciences and Education, Ain Shams University, Heliopolis, Cairo, Egypt *Dina Johar, PhD Department of Biochemistry and Nutrition Faculty of Women for Arts, Sciences, and Education Ain Shams University, Cairo, Egypt Phone:+2 01060782045 Email: dinajohar@gu.edu.eg • To whom correspondence should be addressed Abstract The efficiency of antiviral agents for hepatitis B cirrhosis-related hepatocellular carcinoma (HCC) is still an important clinical challenge with high recurrence rates. In this commentary, we focus on recent findings from Xu et al. We highlight the potential benefit of studying HBV genotypes and subgenotypes as possible mechanisms behind different responses to antivirals. Mechanisms of viral reactivation that parallel HCC recurrence remain uncovered. The commentary is a significant step forward in understanding the nuanced approach to managing HCC recurrence and mortality rate in HBV-cirrhosis patients, offering valuable insights for clinical decision-making. Keywords HBV-related HCC, TDF, TAF, ETV, recurrence, mortality Core Tip A similar virological response to TDF, TAF, and ETV treatment in the first 6-12 months may require further investigation to understand early treatment dynamics. Understanding how HBV genotypes and subgenotypes influence chronic active HBV infection is crucial. Investigating potential molecular mechanisms that explain recurrence rate differences helps develop predictive models for individualized treatment selection. Background The paper entitled “Effect of antiviral therapy on 3-year recurrence and prognosis of hepatocellular carcinoma after curative radiofrequency ablation” by Xu et al. (1) is a robust retrospective cohort study that comprehensively evaluates long-term prognostic effects of advanced nucleos(t)ide analogs (NAs): ETV, TDF, and TAF on HBV-cirrhosis HCC patients post-RFA outcomes. The study identified four independent predictors of post-RFA HCC recurrence. The study findings recommend TDF or TAF as preferred antiviral agents for the long-term management of such patients. The three antiviral agents had a similar impact on the three-year mortality rate. The study used a substantial sample size (n=319) with a follow-up period of 144 weeks, across multiple time points (6, 12, 24, 36 months), although the sample sizes in the TDF (n=76) and TAF (n=52) groups are relatively small. Two of the major determinants of the outcome of chronic HBV infection are the HBV genotypes and subgenotypes. While Xu et al. adhered to established diagnostic guidelines, there are at least ten different confirmed HBV genotypes (A-J). There is limited knowledge about how different genotypes and subgenotypes of HBV affect the risk of HCC recurrence in patients with HBV-cirrhosis related HCC. The best way to find out is through long-term, population-based studies. These studies should compare people with different genotypes and follow them over time. For example, there is a substantial homogeneity of HBV subtypes found in Egypt, a country with a comparably high HBV-cirrhosis-related HCC, mostly genotype D, subgenotype D3, hepatitis B surface antigen (HBsAg) subtype ayw2, with a prevalence of the Major Hydrophilic Region (MHR) mutations (2). Genotype D is related to more advanced liver disease, i.e., HCC, than other genotypes (3) and is an independent risk for Fulminant Hepatitis (FH) (4). Whether new classes of drugs are needed to manage chronic HBV, whether a cure is possible, or even necessary, has not been addressed. The goal of new therapies for chronic hepatitis B should be to achieve a virological cure. Current NAs can slow down HBV replication and help improve liver damage. However, they rarely fully clear chronic HBV infections. There is an urgent need for new drugs and more effective strategies to combat the virus, which eventually will help get rid of the cancer. Still, more research is needed to find clear links between specific genotypes and risks like cirrhosis or HCC. Some research has been carried out in areas such as Asia and Alaska, but many genotypes, including A1 and D, have not been studied in long-term, prospective research. Data is missing for some genotypes and subgenotypes, such as A3, E, F4, and H, regarding their impact on health. Collaboration between multiple institutions from different countries enhances the strength of these studies. Retrospective and prospective studies examined serum HBV DNA levels, liver function, complication rates, and hospital stay duration (5, 6). A study looked at whether high-dose TDF therapy can stop HBV-related HCC recurrence. They designed a study where everyone received the same treatment, with no comparison group. The goal was to determine if using high-dose TDF is practical in real-world settings. They enrolled 10 patients in September 2015 and monitored their progress for three months or until they had to discontinue treatment early. They found that high doses of TDF, up to five times the recommended amount, are poorly tolerated by many patients. These doses also do not effectively stop HBV from replicating as HCC progresses (7). In 2018, a study looked at 607 patients with HBV-related HCC who had surgery or RFA. They divided them into three groups based on their antiviral drugs. The first group, with 261 patients, did not get antiviral treatment. The second group, with 90 patients, received low-strength NAs. The last group, with 256 patients, was treated with high-strength NAs. The main goal was to see how long patients stayed free of cancer recurrence. Patients on ETV and TDF had fewer recurrences than those on other antivirals (8). Another study followed 1,695 patients who had surgery for HBV-related HCC at Korea’s Barcelona Clinic Liver Cancer stage 0 or A between 2010 and 2018. Of these, 813 patients received ETV while 882 took TDF. The study compared cancer recurrence and overall survival between the two groups, using statistical methods to match patients’ backgrounds and adjust for other confounding factors. The analysis started from the day of their liver surgery. Results showed that patients on TDF had a notably lower chance of their HCC recurrence and survived longer overall than those on ETV (9). Between 2013 and 2017, three hospitals enrolled patients with HBV-related HCC who had surgery or ablation as their first treatment. A 421 patients had part of their liver removed, and 305 received RFA. All of these patients started antiviral medication using either ETV or TDF. The study examined HCC recurrence and mortality rates. Researchers adjusted for factors such as HBV DNA levels, tumour characteristics, and patient demographics. The results showed no significant difference in cancer recurrence or death rates between patients treated with ETV and TDF (10). Patients with HCC who go beyond the Milan criteria tend to have a high chance of HCC recurrence post-surgery. When comparing treatments, TDF significantly reduces the risk of HCC recurrence more than ETV therapy (11). Using propensity score matching from the date of liver resection for HCC, TDF showed better overall survival. It also offered stronger protection of liver function. However, in another study, there was no difference in the rate of HCC recurrence between TDF and ETV treatments (12). Other research shows that TDF works better than ETV for eliminating hepatitis B symptoms after RFA treatment. It helps reduce serum HBV DNA levels and improves the albumin-bilirubin (ALBI) grade more effectively (13) (14). A study in 2024 looked at how TDF and ETV affect long-term health in patients with HCC, fatty liver disease, and HBV. The researchers analyzed patient data using a multivariate Cox proportional hazards model and applied a propensity score matching method. They then compared survival outcomes with Kaplan-Meier survival curves. The results showed that TDF helped improve long-term prognosis for patients (15). The latter discovery was confirmed in 2025 in patients with high HBsAg levels after they had their liver removed (16). A study looked back over ten years, finishing in 2025. It included 1,396 patients with HBV-related cirrhotic HCC who had surgery. The patients were divided into two groups: those who took antiviral medicine and those who did not. The research focused on HCC recurrence, taking into account when the antiviral treatment was started, how well the virus was kept under control, and the levels of HBV DNA. Recurrences were labelled as early if they occurred within two years and late if they occurred after that. The study found that long-term antiviral therapy helped prevent late recurrence after surgery, regardless of whether it was started pre- or post-operation. Patients who responded well to the virus treatment saw the biggest benefit (17). Given such controversial results, in Xu et al. study, being a single-center study, there is potential for selection bias inherent in the retrospective study design. The uneven baseline characteristics across treatment groups, potential need for larger sample size to validate findings, and limited exploration of potential mechanisms are behind the differential recurrence rates achieved with TDF, TAF versus ETV, or even behind the similar impact that the three NAs had on the three-year mortality rate. The study will benefit from extending the follow-up period to provide more comprehensive long-term insights. Considering propensity score matching to reduce potential selection bias. Expanding the research scope through multi-center collaborative study enhances external validity and generalizability. Exploring potential interaction effects between NAs and the molecular mechanisms underlying the differential efficacy of TDF and TAF is insightful. Including more diverse patient populations enhances analytical approach, provides a nuanced understanding of anti-HBV agent effectiveness and contributes to a personalized medicine approach in hepatology. Including sensitivity analyses helps validate findings. Declarations Funding This commentary did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The author declare that no honorarium, grant, or other form of payment was given to anyone to produce the manuscript. Conflict of interest The author declares no conflict of interest exists. Consent to publish Not applicable. Availability of data and materials All data generated or analyzed during this study are included in this published article. Acknowledgment N/A References 1. Xu B, Zhang X, Liu F, Li F, Zhang X, Xiang H, et al. Effect of antiviral therapy on 3-year recurrence and prognosis of hepatocellular carcinoma after curative radiofrequency ablation. World J Gastrointest Oncol 2025;17: 112689. 2. Abu Zeid WA RD, Shemis MA,. Prevalence of mutations within major hydrophilic region of hepatitis B virus and their correlation with genotypes among chronically infected patients in Egypt. Arab Journal of Gastroenterology 2016 17 (2016) 34–40. 3. Thakur V, Guptan RC, Kazim SN, Malhotra V, SK. S. Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. . J Gastroenterol Hepatol. 2002;17:165-70. 4. Wai CT, Fontana RJ, Polson J, Hussain M, Shakil AO, Han SH, et al. US Acute Liver Failure Study Group. Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States. J Viral Hepat. 2005 12:192-8. 5. Yuan B, Li R, Yuan W, Xiang B, Zheng M, Yang T, et al. Perioperative entecavir for patients with HBV-related hepatocellular carcinoma and low levels of viral DNA: analysis using propensity score matching. Oncotarget. 2017 16(31):51810-6. 6. Yoo S, Jang J, Kwon J, Jung S, Jang B, Choi J. Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization. . Clin Mol Hepatol. 2016 22:458-65. 7. Hwang S, Song G, Jung D, Yoon Y, Yoo H, Tak E. High-dose tenofovir is not effective in suppressing hepatitis B virus replication in patients with hepatocellular carcinoma progression: a preliminary result. Korean J Hepatobiliary Pancreat Surg.2016(1). 8. Cho H, Ahn H, Lee DH, Lee JH, Jung YJ, Chang Y, et al. Entecavir and tenofovir reduce hepatitis B virus-related hepatocellular carcinoma recurrence more effectively than other antivirals. . Journal of viral hepatitis. 2018;25:707–17. 9. Choi J, Jo C, Lim YS. Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection. Hepatology (Baltimore, Md). 2021 73(661–673). 10. Lee JH, Kim BK, Park SY, Tak WY, Park JY, Kim DY, et al. The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma. . Eur J Intern Med.2021:48-55. 11. Shen J, Qi W, Dai J, Leng S, Jiang K, Zhang Y, et al. Tenofovir vs. entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy. . Chinese medical journal. 2021;135:301–8. 12. Wang XH, Hu ZL, Fu YZ, Hou JY, Li WX, Zhang YJ, et al. Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection. . Journal of gastroenterology. 2022;57:185–98. 13. Hu Z, Zeng H, Hou J, Wang J, Xu L, Zhang Y, et al. Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation. Viruses. 2022;14(656). 14. Giri S, Agrawal D, Afzalpurkar S, Gopan A, Angadi S, Sundaram S. Tenofovir versus entecavir for tertiary prevention of hepatocellular carcinoma in chronic hepatitis B infection after curative therapy: A systematic review and meta-analysis. . Journal of viral hepatitis. 2023;30:108–15. 15. Kong Q GQ, Li W, Chen Z. Effect of tenofovir versus entecavir on the long-term prognosis in hepatocellular carcinoma patients with concurrent metabolic dysfunction-associated steatotic liver disease and hepatitis B. Asian J Surg. 2024 Nov;47(11):4725-4734. doi: 10.1016/j.asjsur.2024.03.147. Epub 2024 Sep 16. PMID: 39289060. 16. Qiu Z XY, Qi W, Shen J, Wen T, Li C. Tenofovir vs Entecavir on the Prognosis of Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma After Liver Resection: The Role of HBsAg Levels. Clin Transl Gastroenterol. 2025 Mar 1;16(3):e00814. doi: 10.14309/ctg.0000000000000814. PMID: 39791573; PMCID: PMC11932590. 17. Liu J BS, Shi X, Yuan T, Yu Y, Lin J, Dai C, Wu Y, Cui L, Zhu B, Fu X, Wang K, Yu W, Li J. Benefits of entecavir therapy in HBV-related hepatocellular carcinoma patients with compensated cirrhosis after hepatectomy: A ten-year retrospective cohort study. Eur J Surg Oncol. 2025 May;51(5):109621. doi: 10.1016/j.ejso.2025.109621. Epub 2025 Jan 23. PMID: 39919509. "  [Collapse]
Xu BG, Zhang X, Liu F, Li FH, Zhang X, Xiang HL, Liang J. Effect of antiviral therapy on 3-year recurrence and prognosis of hepatocellular carcinoma after curative radiofrequency ablation. World J Gastrointest Oncol 2025; 17(11): 112689
13
"This study has provided a combined method including ultrasound and endoscopic examination to present the clinical features of ..."  [Read more]
"This study has provided a combined method including ultrasound and endoscopic examination to present the clinical features of pancreatic cancer in patients with old age. The lifestyles of these patients can be analyzed to perform the potential relationship in the prognosis of pancreatic cancer. In addition, the important features in malignant level as this study displayed may be summarized by author's efforts to indicate significantly and meaningfully in the prognosis of pancreatic cancer in patients. "  [Collapse]
Zignani N, Balzarini M, Dabizzi E, Fracas E, Millefanti L, Segato S, Vecchi M, Cengia G, Missale G, Tontini GE, Moneghini D, Cavallaro F. Endoscopic ultrasound features of pancreatic solid lesions: Descriptive and predictive analysis on a multicenter sample. World J Gastrointest Endosc 2025; 17(11): 112487
14
"The comprehensive review by Professor Elsayed offers a timely and insightful overview of a critical clinical challenge: the management ..."  [Read more]
"The comprehensive review by Professor Elsayed offers a timely and insightful overview of a critical clinical challenge: the management of recurrent hepatocellular carcinoma (RHCC). As a clinician actively managing HCC patients, I find this synthesis of evidence exceptionally valuable. RHCC indeed lacks standardized guidance, and this review effectively consolidates fragmented data across surgical, locoregional, and systemic modalities, offering pragmatic approaches tailored to recurrence patterns (intrahepatic vs. extrahepatic), liver functional reserve, and prior interventions. RHCC complexity demands collaboration between hepatologists, surgeons, interventional radiologists, and oncologists—highlighted here as essential for optimizing outcomes. The candid discussion on limitations—such as the reduced functional liver remnant post-resection/transplant, donor shortages for salvage LT (SLT), and the aggressive biology of RHCC—grounds the review in clinical reality. Coverage of emerging strategies—like combination therapies (TACE + sorafenib), novel ICIs (e.g., atezolizumab/bevacizumab), and AI-driven recurrence prediction—provides hope and direction for ongoing research. While ther are some points for further discussion. In practice, SLT candidates often face adverse factors (e.g., time to recurrence "  [Collapse]
Elsayed MOK. Treatment of recurrent hepatocellular carcinoma: The current standards and future perspectives. World J Gastrointest Oncol 2025; 17(11): 110735
15
"The study provides strong evidence that circulating GDF15 levels are elevated in IBD patients, with a clear correlation to markers ..."  [Read more]
"The study provides strong evidence that circulating GDF15 levels are elevated in IBD patients, with a clear correlation to markers of inflammation and intestinal permeability. This relationship could offer a new avenue for monitoring disease progression and assessing the severity of IBD. The results showing that GDF15 impacts the intestinal barrier function by modulating tight junctions such as ZO-1 and claudin 1 are especially intriguing. From a clinical standpoint, understanding how GDF15 contributes to barrier dysfunction could lead to new therapeutic targets aimed at preventing the "leaky gut" phenomenon, which is a key feature in IBD. One of the most interesting aspects is the suggestion that GDF15 could be a potential biomarker for intestinal permeability, which could be valuable in both clinical diagnosis and disease monitoring. However, as a clinician, I’d like to see more clarity on how these findings might translate into practical treatment strategies. For instance, how could we use this information to develop therapies targeting GDF15 or its signaling pathways in patients with IBD? Additionally, while the in vitro findings are compelling, clinical trials will be essential to confirm whether modulating GDF15 can indeed improve clinical outcomes for IBD patients. "  [Collapse]
Ruiz-Malagón AJ, Herraiz-Vilela M, Serrano-Pino R, García-Ávila P, Díaz-Suárez L, Carmona-Segovia AD, Becerra-Munoz VM, Jiménez-Navarro M, Arranz-Salas I, López-Villodres JA, Fernández-Castañer A, Gutiérrez-Martínez F, Rodríguez-González FJ, Camargo-Camero R, Alcaín-Martínez G, Rodríguez-Díaz C, García-Fuentes E, Sánchez-Quintero MJ, López-Gómez C. Growth differentiation factor 15 alters intestinal barrier and increases permeability: A new molecular target in inflammatory bowel disease. World J Gastroenterol 2025; 31(41): 110955
16
"As a clinician, I found this study highly relevant and practical. The use of VCTE to assess liver fibrosis in PBC patients offers ..."  [Read more]
"As a clinician, I found this study highly relevant and practical. The use of VCTE to assess liver fibrosis in PBC patients offers a non-invasive, reliable alternative to liver biopsies, which is a huge advantage in daily practice. The dual cut-off approach for diagnosing advanced fibrosis seems useful, providing clear thresholds that can guide treatment decisions without the need for invasive procedures. However, the grey area (10-14.5 kPa) remains a challenge, and it would be helpful to have additional tools or markers for better decision-making in these cases. Overall, this study offers a valuable, non-invasive method for fibrosis assessment, but more research on managing patients in the grey zone would be beneficial. "  [Collapse]
Chen JL, Hou YX, Liu Y, Jiang YY, Wang XB. Real-world performance of transient elastography in assessing advanced fibrosis in Chinese patients with primary biliary cholangitis. World J Gastroenterol 2025; 31(41): 111256
17
"Transient Elastography is an easy, bedside, non-invasive test for assessing liver fibrosis. PBC is a condition for which earlier ..."  [Read more]
"Transient Elastography is an easy, bedside, non-invasive test for assessing liver fibrosis. PBC is a condition for which earlier diagnosis and treatment are associated with a better prognosis. So, evaluating Fibrosis has important diagnostic and therapeutic implications in PBC. However, studies on TE in PBC are limited to Asian settings, and the study by Jia-Liang Chen provides important data in this subset. In this retrospective study, they compared TE with the gold-standard findings of liver biopsy. They showed that TE is highly accurate for diagnosing Advanced fibrosis, and LSM has outperformed other fibrotic markers in ROC curves. Furthermore, they have classified patients with LSM into early, indeterminate, and late stages based on the LSM cut-off; these stages may have future prognostic significance. Future Prospective observational studies can be conducted to assess changes in LSM with treatment, disease progression, or complications. "  [Collapse]
Chen JL, Hou YX, Liu Y, Jiang YY, Wang XB. Real-world performance of transient elastography in assessing advanced fibrosis in Chinese patients with primary biliary cholangitis. World J Gastroenterol 2025; 31(41): 111256
18
"The authors presented a case of pancreatic tuberculosis and provided a detailed analysis of the diagnostic process, which holds ..."  [Read more]
"The authors presented a case of pancreatic tuberculosis and provided a detailed analysis of the diagnostic process, which holds significant reference value for the diagnosis of similar cases. However, the report lacks an in-depth discussion and evaluation of the treatment approach and therapeutic strategy employed in this case, thereby limiting its applicability in guiding clinical management of analogous conditions. Consequently, the inclusion of a comprehensive treatment plan would substantially enhance the clinical utility and overall contribution of this case report. "  [Collapse]
Nima CL, Wang HG, Zhou Q. Pancreatic tuberculosis: A case report and review of literature. World J Gastroenterol 2025; 31(41): 110398
19
"This study has compared several computational methods to be used in the predication of prognosis for acute variceal bleeding in ..."  [Read more]
"This study has compared several computational methods to be used in the predication of prognosis for acute variceal bleeding in cirrhosis patients. Author claimed that the convolution network by their efforts displayed the best effect in the outcomes analysis rather than another methods. However, the specific features in different subgroups with data presentations using AI or other computational methods lacked in the full analysis to be performed in the compared computation process. This means that this study only provides the end result for supporting their analysis as they wanted. In addition, the standard between high and low risk group presented to differ significantly without clinical parameters in this study. "  [Collapse]
Xiang Y, Yang N, Zheng TL, Huang YF, Liu TY, Ma DQ, Hu SJ, Zhang WH, Xiang HL, Zhang LY, Yuan LL, Wang X, Dang T, Zhang G, Wu B, Peng LJ, Gao M, Xia DL, Liu ZB, Li J, Song Y, Zhou XQ, Qi XS, Zeng J, Tan XY, Deng MM, Fang HM, Qi SL, He S, He YF, Ye B, Wu W, Shao JB, Wei W, Hu JP, Yong X, He CH, Bao JL, Zhang YN, Ji R, Bo Y, Yan W, Li HJ, Li SL, Geng S, Zhao L, Liu B, Qi XL. Development of a deep learning model for guiding treatment decisions of acute variceal bleeding in patients with cirrhosis. World J Gastroenterol 2025; 31(41): 111361
20
"This article is a well-conducted clinical study that elucidates the psychological profiles of patients undergoing esophagectomy for ..."  [Read more]
"This article is a well-conducted clinical study that elucidates the psychological profiles of patients undergoing esophagectomy for esophageal cancer. Its core contributions lie in: 1. Demonstrating a significant negative correlation among anxiety, depression, and mindfulness, advancing understanding of the mind–body interaction in surgical oncology; 2. Identifying key demographic and clinical risk factors that shape postoperative emotional outcomes, thereby guiding individualized psychological assessment and intervention. By linking psychometric evaluation with perioperative management, this study offers a valuable reference for integrating mindfulness-based strategies into holistic recovery pathways. "  [Collapse]
Deng X, Hu YH, Xiong YJ, Mao N, Hong B, He G. Correlation of anxiety and depression with mindfulness in esophageal cancer patients undergoing esophagectomy and analysis of risk factors. World J Psychiatry 2025; 15(9): 104813
1110 items  Read more >>
Write to the Help Desk
  • ALL AUTHOR RESOURCES
  • Allegations of Misconduct
  • Appeals and Complaints
  • Article Processing Charge
  • Common Usage of Quantities and Units
  • Copyright License Agreement
  • Create an Account
  • Criteria for Authorship
  • Ethics Committee of BPG
  • Ethics Statements
  • Guidelines for Authors
  • Journals
  • Language Editing Process for Manuscripts Submitted by Non-Native Speakers of English
  • Methods of Post-Publication Debate
  • Open-Access
  • Publication Misconduct
  • Quality of Publications
  • Steps for Submitting Manuscripts
  • Submit a Manuscript
  • ALL PEER-REVIEWER RESOURCES
  • Manuscript Decision
  • Peer-Review Process
  • Peer-Reviewer Tracking for Manuscripts
  • Reviewer Acknowledgment
  • REFERENCE CITATION ANALYSIS
  • Find a Category
  • Find a Journal
  • Find a Scholar
  • Find an Academic Assistant
  • Find an Article
  • Find an Article PDF
  • Subscribe
  • Today's Articles
  • ALL PUBLISHER RESOURCES
  • About the BPG
  • BPG Home
  • Company Registration
  • Contact Us
  • ICMJE Conformity
  • Management Team
  • Membership
  • Ownership
  • Permissions
  • Privacy Policy
  • Publication Ethics
  • Publisher
  • Publishing Credentials
  • Revenue Sources
  • Special Statement
  • Terms of Use
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345